Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

bulk quadrivalent influenza vaccine (split virion, inactivated) thiomersal containing

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram/ml - injection, suspension - excipient ingredients: monobasic potassium phosphate; water for injections; thiomersal; calcium chloride dihydrate; dibasic sodium phosphate; potassium chloride; sodium chloride; monobasic sodium phosphate - for active immunization against influenza disease caused by influenza subtype viruses and type b viruses contained in the vaccine.

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled syringe without needle, SH2024 influenza season Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.

INFLUENZA - influenzinum (combo), histaminum hydrochloricum, aconitum nap., aralia quinquefolia, arsenicum alb., baptisia, bryon Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

influenza - influenzinum (combo), histaminum hydrochloricum, aconitum nap., aralia quinquefolia, arsenicum alb., baptisia, bryon

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinc - influenza a virus 35 [hp_x] in 1 ml - influenza   formulated for symptoms associated with colds and flu such as aches, discomfort, fatigue, respiratory dysfunction and digestive upset.

INFLUENZA - influenzinum (combo), histaminum hydrochloricum, aconitum nap., aralia quinquefolia, arsenicum alb., baptisia, bryon Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

influenza - influenzinum (combo), histaminum hydrochloricum, aconitum nap., aralia quinquefolia, arsenicum alb., baptisia, bryon

newton laboratories, inc. - influenza a virus (unii: r9hh0nde2e) (influenza a virus - unii:r9hh0nde2e), influenza b virus (unii: 1314jz2x6w) (influenza b virus - unii:1314jz2x6w), histamine dihydrochloride (unii: 3poa0q644u) (histamine - unii:820484n8i3), aconitum napellus (unii: u0nq8555jd) (aconitum napellus - unii:u0nq8555jd), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), baptisia tinctoria root (unii: 5ef0hwi5wu) (baptisia tinc - influenza a virus 35 [hp_x] in 1 g - influenza   formulated for symptoms associated with colds and flu such as aches, discomfort, fatigue, respiratory dysfunction and digestive upset.

PANDEMRIX H5N1 pandemic influenza vaccine (split virion, inactivated, AS03 adjuvanted) 2.5 mL injection suspension vial composit Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

pandemrix h5n1 pandemic influenza vaccine (split virion, inactivated, as03 adjuvanted) 2.5 ml injection suspension vial composit

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 3.75 microgram - injection, suspension - excipient ingredients: water for injections; polysorbate 80; magnesium chloride hexahydrate; sodium chloride; thiomersal; potassium chloride; dibasic sodium phosphate dodecahydrate; octoxinol 10; monobasic potassium phosphate - prophylaxis of influenza in an officially declared pandemic situation. pandemrix h5n1 should be used in accordance with official recommendations.

CSL Bulk Influenza Vaccine (Split virion inactivated). Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

csl bulk influenza vaccine (split virion inactivated).

seqirus pty ltd - influenza virus haemagglutinin, quantity: 30 microgram/ml - injection, suspension - excipient ingredients: monobasic potassium phosphate; thiomersal; calcium chloride dihydrate; dibasic sodium phosphate; sodium chloride; potassium chloride; monobasic sodium phosphate; water for injections - indicated for the prevention of influenza caused by influenza virus, types a and b.

PANDEMRIX H1N1 pandemic influenza vaccine split virion inactivated AS03 adjuvanted 0.5 mL dose Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

pandemrix h1n1 pandemic influenza vaccine split virion inactivated as03 adjuvanted 0.5 ml dose

glaxosmithkline australia pty ltd - influenza virus haemagglutinin -

Adjupanrix Pandemic Influenza Vaccine (split virion inactivated AS03 adjuvanted) Singapūra - angļu - HSA (Health Sciences Authority)

adjupanrix pandemic influenza vaccine (split virion inactivated as03 adjuvanted)

glaxosmithkline pte ltd - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) - injection, emulsion - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) 3.75 µg haemagglutinin/dose

Foclivia Eiropas Savienība - angļu - EMA (European Medicines Agency)

foclivia

seqirus s.r.l.  - influenza virus surface antigens, inactivated: a/viet nam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenza vaccines - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Vaxigrip Formulation: Each dose (0.5 mL) contains the following influenza strains*: A/Victoria/2570/2019 (HINI)pdm09-like stra Filipīnas - angļu - FDA (Food And Drug Administration)

vaxigrip formulation: each dose (0.5 ml) contains the following influenza strains*: a/victoria/2570/2019 (hini)pdm09-like stra

sanofi pasteur, inc.; distributor: zuellig pharma corporation - trivalent seasonal influenza vaccine (split virion, inactivated) 2022 southern hemisphere strain - suspension for injection (im/sc) - formulation: each dose (0.5 ml) contains the following influenza strains*: a/victoria/2570/2019 (hini)pdm09-like strain 15 ug